Two new patents in Japan

You are here

Lyon, 27 July 2016 - Amoéba announced today that it has obtained two new patents in Japan and one in Europe, all three contributing to its objective to develop new applications for its biological biocide. The first patent, issued in Japan by the Japanese Patents Office, confirms that AMOEBA’s solution has biocidal action against the pathogenic bacteria Pseudomonas, primary germ implicated in nosocomial infections acquired in health-care institutions. It applies to the Domestic Hot Water sector. The second patent was issued for Japan by the Japanese Patents Office, while its equivalent was issued for the European zone by the European Patents Office. Both patents confirm that AMOEBA’s solution has biocidal action against the pathogenic bacteria Listeria, which is frequently implicated in food-borne infections. They relate to water used to clean equipment and material which will come into contact with foodstuffs and animal feed.

“The two new patents issued in Japan will soon open extensive commercial perspectives for us in the world’s 3rd largest economy.  Japan has a dense and diverse industrial network covering numerous activity sectors; the country is brimming with opportunities for a growing company like AMOEBA, which offers a biological alternative to enterprises involved in the field of water treatment.” declares Fabrice Plasson, President of AMOEBA’s Board of Directors.

Related Posts